Savvy Updates 8/28/23: Roche Solo MicroPump FDA-Approved, Altucell Islet Cell Encapsulation, Abata Therapeutics TReg Therapies, Dexcom/Abbott Go Direct to Customer, Lots of NEW Advanced Diabetes Tech, Insulet Stock Down, Medtronic Q1 2024 Earnings,
FDA Approves New Tubeless Insulin Pump by Miriam Tucker for MedScape.com, 23 August 2023. The US Food and Drug Administration (FDA) has granted clearance for Roche’s Accu-Chek Solo micropump system, a tubing-free “patch” pump for people with diabetes...
Savvy Updates 8/21/23: Insulet Sues EOFlow for Patent Infringement, Lilly/Sigilon Deal Complete, Amazon Pharmacy Gives Insulin Coupons, DEKA Pump 501K Approval, Oramed’s Human Insulin, Antidepressants & T1D, Cannabis & DKA, Female T1D SD, 2 Videos from TheSugarScience
Insulet claims EOFlow copied patch-pump design in patent suit by Elise Reuter for MedTechDive.com, 15 August 2023. Insulet claims that EOFlow’s EOPatch insulin pump violates three of the patents for its Omnipod patch pump and that the product designs “are practically...
Savvy Updates, 8/14/23: Medicare Covers Libre 3, Senseonics Seeks iCGM Designation, 5000 Steps are Enough, New Bill to Expand Drug Negotiations Under Medicare, Chinese microbial DPP4, Green Space & Blood Pressure, GLP-1 Agonists & Retinopathy, Satisfy Your Sweet Tooth, Take an Insulin Pump Vacation – Be Prepared
Medicare Covers FreeStyle Libre 3 CGM by Andrew Briskin and April Hopcroft for diaTribe.org, 4 August 2023. Abbott has announced that its latest continuous glucose monitor, the FreeStyle Libre 3, is now covered under Medicare. Following news in April that...
Savvy Updates, 8/7/23: Tandem to Integrate with G7 & Libre 2/3 by Q4/23, Eversense, Glucotrack Implantable CGM, Glytec Glucommander for Hospitals, Insulin-like Hormones & Brain Plasticity, Climate Change & T1D, Female Sexual Dysfunction & T1D, Kombucha Benefits, Mayo Clinic BEST for Diabetes Care, CKM Data, Canada Supports Do-It-Yourself Automated Insulin Delivery
Tandem’s Control-IQ to Integrate Dexcom G7 and FreeStyle Libre 2 as announced in the Tandem Diabetes Care, Inc., Q2 2023 Earning Call, 3 August 2023. According to John Sheridan, CEO: “We want our customers to have the benefits of the latest CGM...
Savvy Update 7/31/23: SiBio Ketone Monitor, Time in Range (or TTIR), User Reviews (iLet, Dexcom G7), Aging & T1DD (EDIC), Report Device Issues to FDA, 9 Genes that Cause T1D, Strawberries & Health, More TCOYD Videos
Continuous Ketone Monitoring – a world’s first from SiBio? by Tim Street for Diabettech.com, 17 July 2023. SiBio describes itself as “an innovative company with medical active implant and medical artificial intelligence research and development as its core...
More Diabetes Blogs